JPS6154008B2 - - Google Patents

Info

Publication number
JPS6154008B2
JPS6154008B2 JP53089306A JP8930678A JPS6154008B2 JP S6154008 B2 JPS6154008 B2 JP S6154008B2 JP 53089306 A JP53089306 A JP 53089306A JP 8930678 A JP8930678 A JP 8930678A JP S6154008 B2 JPS6154008 B2 JP S6154008B2
Authority
JP
Japan
Prior art keywords
factor
plasma
copolymer
cross
maleic anhydride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53089306A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5426322A (en
Inventor
Jeen Josefu Derente Jatsukusu
Aran Shooenfuerudo Richaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of JPS5426322A publication Critical patent/JPS5426322A/ja
Publication of JPS6154008B2 publication Critical patent/JPS6154008B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP8930678A 1977-07-25 1978-07-21 Separating of nineth factor preparation from serum Granted JPS5426322A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/818,920 US4081432A (en) 1977-07-25 1977-07-25 Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers

Publications (2)

Publication Number Publication Date
JPS5426322A JPS5426322A (en) 1979-02-27
JPS6154008B2 true JPS6154008B2 (enExample) 1986-11-20

Family

ID=25226755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8930678A Granted JPS5426322A (en) 1977-07-25 1978-07-21 Separating of nineth factor preparation from serum

Country Status (15)

Country Link
US (1) US4081432A (enExample)
EP (1) EP0000651B1 (enExample)
JP (1) JPS5426322A (enExample)
AT (1) AT359645B (enExample)
AU (1) AU517885B2 (enExample)
CA (1) CA1107649A (enExample)
DE (1) DE2861573D1 (enExample)
ES (1) ES471857A1 (enExample)
HU (1) HU180882B (enExample)
IL (1) IL55194A0 (enExample)
IT (1) IT1097302B (enExample)
MX (1) MX5405E (enExample)
PT (1) PT68337B (enExample)
RO (1) RO75338A (enExample)
SU (1) SU841572A3 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
ES471858A1 (es) * 1977-07-25 1979-02-01 Monsanto Co Un metodo para separar el factor especifico de coagulacion de la sangre de una mezcla con otras proteinas de la sangre en un medio fluido
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
AT368883B (de) 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
US4435318A (en) 1981-05-22 1984-03-06 Ionics, Incorporated Electrodialysis preparation of purified AHF concentrate
US4447416A (en) * 1982-04-28 1984-05-08 American National Red Cross Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US4382028A (en) * 1982-07-19 1983-05-03 Monsanto Company Separation of plasma proteins from cell culture systems
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
DE3627762A1 (de) * 1986-08-16 1988-02-18 Behringwerke Ag Verfahren zur herstellung einer prothrombin-armen praeparation vitamin k-abhaengiger gerinnungsfaktoren, sowie ein danach erhaeltliches mittel
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
KR100447685B1 (ko) * 1995-08-28 2004-12-03 세키스이 가가쿠 고교 가부시키가이샤 혈청또는혈장분리용조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554985A (en) * 1963-01-02 1971-01-12 Monsanto Co Cross-linked copolymer polyelectrolytes based on alpha,beta-ethylenically unsaturated acids
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3555001A (en) * 1969-05-29 1971-01-12 Monsanto Co Process for the fractionation of plasma and serum using water-insoluble polyelectrolytes containing diloweralkylaminoloweralkylimide groups
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
IL42254A (en) * 1973-05-13 1977-03-31 Yeda Res & Dev Polymeric carrier for biologically active proteins and biologically active substances based on these
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
DE2534603C2 (de) * 1975-08-02 1984-10-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Copolymerisaten mit N-Dialkyl-N-amido-Gruppen

Also Published As

Publication number Publication date
EP0000651A1 (en) 1979-02-07
ES471857A1 (es) 1979-02-01
SU841572A3 (ru) 1981-06-23
EP0000651B1 (en) 1982-01-27
HU180882B (en) 1983-05-30
US4081432A (en) 1978-03-28
AT359645B (de) 1980-11-25
PT68337B (pt) 1994-02-25
DE2861573D1 (en) 1982-03-11
IL55194A0 (en) 1978-09-29
CA1107649A (en) 1981-08-25
IT1097302B (it) 1985-08-31
MX5405E (es) 1983-07-13
RO75338A (ro) 1980-11-30
ATA531778A (de) 1980-04-15
AU517885B2 (en) 1981-09-03
AU3824378A (en) 1980-01-24
IT7826005A0 (it) 1978-07-21
PT68337A (en) 1978-08-01
JPS5426322A (en) 1979-02-27

Similar Documents

Publication Publication Date Title
JPS6154008B2 (enExample)
US4160025A (en) Method of producing a blood-coagulation-promoting preparation from human blood plasma
US4297344A (en) Blood coagulation factors and process for their manufacture
CA2201714C (en) Method for isolation of highly pure von willebrand factor
Nilsson et al. Characteristics of various factor VIII concentrates used in treatment of haemophilia A
US4331766A (en) Collagen solution, process for its manufacture and its use
CA2006658C (en) An anticoagulant substance obtained from urine
AU6747090A (en) A method for isolating factor viii
US4397841A (en) Production of blood coagulation factor VIII:C
JPS6160614A (ja) 第８因子製剤およびその製造方法
EP0032655A1 (en) A process in purification and concentration of the factor VIII-complex
GB1591333A (en) Process for the preparation of thrombin-like enzymes from snake venoms
JPH0424360B2 (enExample)
US4097473A (en) Production of serum albumin
US4822872A (en) Method of purifying factor VIII
US5043428A (en) Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
US4361510A (en) Blood coagulation promoting product
EP0052874A1 (en) Method for synthesizing procoagulant factor VIII activity
EP0041174B1 (en) Blood coagulation promoting product and process of preparing same
US4471112A (en) Heparin polyelectrolyte polymer complex
GB1563009A (en) Antihaemophilic agent and process for its manufacture
CA1041424A (en) Isolation of coagulation factors from biological material
Boisson-Vidal et al. Adsorption of human antibodies to factor VIII: C to insoluble modified polystyrene from plasma
JPS59167519A (ja) 不活化トロンビンゲルにより血漿タンパク質混合液からフイブリノ−ゲンを除去する方法
JPH065230B2 (ja) 血液凝固促進剤